Researchers from Columbia University Medical Center (CUMC) have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss.
The approach, the first of its kind, takes advantage of induced pluripotent stem (iPS) cell technology to transform skin cells into retinal cells, which are then used as a patient-specific model for disease study and preclinical testing.
Regeneration of Retinal Ganglion Cell Axons and Gene Therapy
The adult mammalian central nervous system has only limited intrinsic capacity to regenerate connections after injury.
Advertisement
Using this approach, researchers led by Stephen H. Tsang, MD, PhD, showed that a form of RP caused by mutations to the gene MFRP (membrane frizzled-related protein) disrupts the protein that gives retinal cells their structural integrity. They also showed that the effects of these mutations can be reversed with gene therapy. The approach could potentially be used to create personalized therapies for other forms of RP, as well as other genetic diseases. The paper was published recently in the online edition of Molecular Therapy, the official journal of the American Society for Gene & Cell Therapy.
"The use of patient-specific cell lines for testing the efficacy of gene therapy to precisely correct a patient's genetic deficiency provides yet another tool for advancing the field of personalized medicine," said Dr. Tsang, the Laszlo Z. Bito Associate Professor of Ophthalmology and associate professor of pathology and cell biology.
Source: Eurekalert
Source: Eurekalert
Cellular Mechanism Involved in Memory Consolidation may Develop Gene Therapy
The first cause of dementia is Alzheimer's disease and it affects some 400,000 people in Spain alone. However, no effective cure has been found till now.
Advertisement
 Bionic Ear Technology Used for Gene Therapy may Help Restore Hearing QualityNew research suggests that the quality of hearing among people who have impaired hearing can be improved by using bionic ear technology. | Advertisement
|
Friedreich's Ataxia - an Effective Gene Therapy in Mice Model
In mice, the transfer via a viral vector of a normal copy of the gene deficient in patients, allowed to fully and very rapidly cure the heart disease.
Advertisement
Recommended Reading
Latest Research News
Studies using brain scans shows that how our brain helps us experience and remember our daily surroundings.
Scientists explore a potential mechanism that a jawless fish called the lampreys employs to swim again after spinal cord injuries.
New study finds that lesbian, gay, and bisexual (LGB) preteens exhibit more social media and mobile phone addiction than straight peers.
The model for memory consolidation claims that the hippocampus forms new memories and, as time goes on, trains the cortex to store enduring memories.
A new study explored the link between T immune cells in ill patients and mortality risk.